PulseAugur
中
实时 07:57:51
English(EN) Discovery of new antiviral agents through artificial intelligence: in vitro and in vivo results

AI设计靶向流感病毒的新型抗病毒化合物

研究人员利用深度强化学习平台设计了靶向流感病毒的新型抗病毒化合物。AI生成了超过60,000种化合物,其中大部分化合物的理化性质优于奥司他韦。两种确定的化合物 DS-22-inf-009 和 DS-22-inf-021,对包括耐药菌株在内的甲型和乙型流感病毒均表现出有效的体外抑制作用。在小鼠体内研究中显示出对感染的显著保护作用,突显了AI在加速发现有效抗病毒药物方面的潜力。 AI

影响 通过展示AI生成有效抗病毒化合物的能力,加速药物发现流程。

排序理由 详细介绍AI驱动发现新型抗病毒药物的研究论文。[lever_c_demoted from research: ic=1 ai=1.0]

在 arXiv cs.LG 阅读 →

AI 生成摘要 · Google Gemini · 来自 1 个来源。 我们如何撰写摘要 →

AI设计靶向流感病毒的新型抗病毒化合物

本文如何被排名

Signal score
26 / 100
Composite score across the factors below. Higher = stronger signal that this story matters right now.
Newsworthiness bucket
Tool
详细介绍AI驱动发现新型抗病毒药物的研究论文。[lever_c_demoted from research: ic=1 ai=1.0]
Source corroboration
Single-source cluster
Only one publisher covered this so far. Single-source stories can still rank when the publisher is high-authority, but they lack cross-source corroboration.
Topics
paper, model release
Editorial topic classification. Feeds into how the story surfaces on /topic/<slug> hub pages and into the per-entity coverage mix.
AI-industry relevance
High
Clearly on-topic for AI-industry coverage.
Story freshness
Breaking (< 6h)
Fresh story with cross-source coverage still developing. Ranking may shift as more sources report.

完整方法见我们的编辑标准。

报道来源 [1]

  1. arXiv cs.LG TIER_1 English(EN) · Roza Izmailyan, Mher Matevosyan, Hamlet Khachatryan, Anastasiya Shavina, Smbat Gevorgyan, Artur Ghazaryan, Irina Tirosyan, Yeva Gabrielyan, Marusya Ayvazyan, Boris Martirosyan, Vardan Harutyunyan, Hovakim Zakaryan ·

    人工智能发现新型抗病毒药物:体外和体内结果

    arXiv:2611.22230v1 Announce Type: cross Abstract: In this research, we employed a deep reinforcement learning (RL)-based molecule design platform to generate a diverse set of compounds targeting the neuraminidase (NA) of influenza A and B viruses. A total of 60291 compounds were …